All News

Massachusetts' Harvard Pilgrim Health Care has instituted a policy shift excluding coverage of prescription drugs compounded for adults. Plaintiffs call this "a callous decision" and "a major blow" to the state's many patients who depend on compounded medications.

As a healthcare model, the PCMH is a work in progress, but all signs point to its increasing importance. And pharmacists are key members of the team.

Indianapolis pharmacists and the college of pharmacy at Butler University brainstorm solutions to the problem of medication adherence in a live CE program.

An estrogen receptor agonist, ospemifene counteracts the effects of declining estrogen hormones on vaginal tissue, thereby reducing pain during intercourse.

The Hundred Years’ War

The War on Drugs began a century ago. It's still going strong -- and so is the traffic in illegal drugs. What's up with that?

Voices 09-15-2013

Drug Topics readers weigh in on natural medicines, foreign-made pharmaceuticals, and drugstore tobacco sales.

Filling a prescription at a doctor’s office may be convenient, but it’s certainly no bargain for patients or taxpayers, according to an analysis of workers’ compensation payouts in Maryland and Pennsylvania.

After Adheris, Inc. sought a preliminary injunction to block a rule that would prevent companies from sending Rx refill reminders to patients, the U.S. Department of Health and Human Services has delayed its implementation.

CDC Director Tom Frieden, MD, praised the components of the ACA that have already been rolled out and emphasized that a number of provisions have already made in impact. He spoke at a September 10 gathering at the National Press Club in Washington, D.C.

Walgreens has reached agreement with privately held Kerr Drug to acquire its retail drugstores and specialty pharmacy business, which last year had sales of about $381 million.

Poor medication adherence causes more frequent hospitalizations and emergency department visits among children and adolescents who have a chronic medical condition, such as asthma and type 1 diabetes, according to a study recently published in Pediatrics.

In hopes of decreasing opioid abuse, addictions, and overdose deaths, FDA this week announced safety-labeling changes for all extended-release and long-acting opioid analgesics used to treat pain. FDA has also added new postmarket study requirements for opioids such as morphine, oxycodone, and fentanyl.

At least one quarter of the 800,000 deaths annually attributed to cardiovascular disease could be prevented if people stopped smoking, reduced salt intake, and adopted other healthy habits, according to a report by the U.S. Centers for Disease Control and Prevention.

Knowing which patients are most at-risk for adverse drug events would help hospitals direct pharmacist-led counseling services to those who need it the most. The American Society of Health-System Pharmacists (ASHP) Foundation is funding research it believes will make it easier to identify those patients.